KOEN VENKEN to Natural Killer T-Cells
This is a "connection" page, showing publications KOEN VENKEN has written about Natural Killer T-Cells.
Connection Strength
3.043
-
Tregs protect against invariant NKT cell-mediated autoimmune colitis and hepatitis. Immunology. 2024 Feb; 171(2):277-285.
Score: 0.803
-
ROR?t inhibition selectively targets IL-17 producing iNKT and ?d-T cells enriched in Spondyloarthritis patients. Nat Commun. 2019 01 02; 10(1):9.
Score: 0.572
-
Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition. Haematologica. 2017 07; 102(7):e266-e270.
Score: 0.507
-
Lipidomic scanning of self-lipids identifies headless antigens for natural killer T cells. Proc Natl Acad Sci U S A. 2024 Aug 20; 121(34):e2321686121.
Score: 0.211
-
ER stress in antigen-presenting cells promotes NKT cell activation through endogenous neutral lipids. EMBO Rep. 2020 06 04; 21(6):e48927.
Score: 0.157
-
4"-O-Alkylated a-Galactosylceramide Analogues as iNKT-Cell Antigens: Synthetic, Biological, and Structural Studies. ChemMedChem. 2019 01 08; 14(1):147-168.
Score: 0.143
-
Checkpoint inhibition in the treatment of multiple myeloma: A way to boost innate-like T cell anti-tumor function? Mol Immunol. 2018 09; 101:521-526.
Score: 0.140
-
Altered thymic differentiation and modulation of arthritis by invariant NKT cells expressing mutant ZAP70. Nat Commun. 2018 07 06; 9(1):2627.
Score: 0.138
-
Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myeloma. Leukemia. 2017 12; 31(12):2678-2685.
Score: 0.128
-
Synthesis of C6''-modified a-C-GalCer analogues as mouse and human iNKT cell agonists. Org Biomol Chem. 2017 Mar 08; 15(10):2217-2225.
Score: 0.126
-
Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma? Oncotarget. 2016 Apr 26; 7(17):23128-40.
Score: 0.119